SCHEMBL8937409

SCHEMBL8937409

CCCOc1ccc(-c2cccc(/C=C/C(=O)O)c2)cc1OCCC

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.65
KMT2A Q03164 2/20 0.60
GAA P10253 1/20 0.60
AKR1C3 P42330 4/20 0.56
POLB P06746 1/20 0.55
ALDH1A1 P00352 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 1/20 0.52
MEN1 O00255 1/20 0.51
ACHE P22303 3/20 0.47
PIM2 Q9P1W9 1/20 0.46
SNCA P37840 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
PTPN11 Q06124 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8937412 1.00 KDM4E (0.65) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937414 1.00 KDM4E (0.65) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937454 0.94 KDM4E (0.76) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937290 0.94 KDM4E (0.76) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937281 0.94 KDM4E (0.76) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8999245 0.88 KDM4E (0.70) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937349 0.88 KDM4E (0.67) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937352 0.88 KDM4E (0.67) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937445 0.88 KDM4E (0.67) KDM4EKMT2AGAAAKR1C3POLB
SCHEMBL8937665 0.86 KDM4E (0.58) KDM4EKMT2AGAAAKR1C3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0395446-B1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists SANKYO CO (JP) 1995-03-01 EP disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed
EP-0395446-A2 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists Sankyo Company Limited (JP) 1990-10-31 EP disclosed